SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-066948
Filing Date
2021-05-14
Accepted
2021-05-14 17:00:46
Documents
49
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2113993d1_10q.htm 10-Q 400976
2 EXHIBIT 31.1 tm2113993d1_ex31-1.htm EX-31.1 8582
3 EXHIBIT 31.2 tm2113993d1_ex31-2.htm EX-31.2 8525
4 EXHIBIT 32.1 tm2113993d1_ex32-1.htm EX-32.1 3919
5 EXHIBIT 32.2 tm2113993d1_ex32-2.htm EX-32.2 4125
  Complete submission text file 0001104659-21-066948.txt   3264983

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snpx-20210331.xml EX-101.INS 507790
7 XBRL TAXONOMY EXTENSION SCHEMA snpx-20210331.xsd EX-101.SCH 47784
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snpx-20210331_cal.xml EX-101.CAL 24167
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snpx-20210331_def.xml EX-101.DEF 148981
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20210331_lab.xml EX-101.LAB 321453
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20210331_pre.xml EX-101.PRE 272766
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-249434 | Film No.: 21925725
SIC: 2834 Pharmaceutical Preparations